EarningsQ4 2023 Earnings Report

Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Report

0 Followers

MX:VRTX Q4 2023 EPS Results

Actual EPS$71.99

Consensus EPS$69.71

Beat/MissBeat by +$2.28

One Year Ago EPS$64.45

Actual Revenue$43.21B

Expected Revenue$43.07B

Beat/MissBeat by +$131.89M

YoY Revenue Growth+12.00%

QuarterQ4 2023

Date02/05/2024

TimeAfter Close

Conference CallMonday, February 5, 2024

MX:VRTX Upcoming Earnings

Vertex Pharmaceuticals's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

MX:VRTX Q4 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 09, 2026	2026 (Q3)	81.76 / -	82.279	―
Aug 03, 2026	2026 (Q2)	81.27 / 81.08	77.48	4.65% (+3.60)
May 04, 2026	2026 (Q1)	72.73 / 76.62	69.594	10.10% (+7.03)
Feb 12, 2026	2025 (Q4)	87.61 / 86.22	68.223	26.38% (+18.00)
Nov 03, 2025	2025 (Q3)	78.39 / 82.28	75.08	9.59% (+7.20)
Aug 06, 2025	2025 (Q2)	73.50 / 77.48	-219.925	135.23% (+297.40)
May 05, 2025	2025 (Q1)	74.00 / 69.59	81.593	-14.71% (-12.00)
Feb 10, 2025	2024 (Q4)	68.84 / 68.22	71.994	-5.24% (-3.77)
Nov 04, 2024	2024 (Q3)	69.90 / 75.08	69.937	7.35% (+5.14)
Aug 01, 2024	2024 (Q2)	-199.29 / -219.93	66.68	-429.82% (-286.61)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed